← Back
Data updated: Mar 10, 2026
PHARMACHEMIE BV
OncologyImmunology
PHARMACHEMIE BV is a generic drug manufacturer focused on Oncology, Immunology.
1990
Since
6
Drugs
-
Trials
31
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CARBOPLATIN 2026-02-04
DOXORUBICIN HYDROCHLORIDE 2026-02-03
METHOTREXATE SODIUM PRESERVATIVE FREE 2026-01-14
Labeling
METHOTREXATE SODIUM PRESERVATIVE FREE 2026-01-14
Labeling
METHOTREXATE SODIUM PRESERVATIVE FREE 2025-08-18
Labeling
METHOTREXATE SODIUM PRESERVATIVE FREE 2025-08-18
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-25
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-25
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-25
Labeling
DOXORUBICIN HYDROCHLORIDE 2025-06-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 75%
3 drugs
Immunology 25%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (3)
Company Info
- First Approval
- 1990-05-21
- Latest
- 2026-01-14
- Applications
- 8